Cargando…
Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants
Soft tissue tumors of infancy encompass an overlapping spectrum of diseases that pose unique diagnostic and clinical challenges. We studied genomes and transcriptomes of cryptogenic congenital mesoblastic nephroma (CMN), and extended our findings to five anatomically or histologically related soft t...
Autores principales: | Wegert, Jenny, Vokuhl, Christian, Collord, Grace, Del Castillo Velasco-Herrera, Martin, Farndon, Sarah J., Guzzo, Charlotte, Jorgensen, Mette, Anderson, John, Slater, Olga, Duncan, Catriona, Bausenwein, Sabrina, Streitenberger, Heike, Ziegler, Barbara, Furtwängler, Rhoikos, Graf, Norbert, Stratton, Michael R., Campbell, Peter J., Jones, David TW, Koelsche, Christian, Pfister, Stefan M., Mifsud, William, Sebire, Neil, Sparber-Sauer, Monika, Koscielniak, Ewa, Rosenwald, Andreas, Gessler, Manfred, Behjati, Sam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006309/ https://www.ncbi.nlm.nih.gov/pubmed/29915264 http://dx.doi.org/10.1038/s41467-018-04650-6 |
Ejemplares similares
-
High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro
por: Wegert, Jenny, et al.
Publicado: (2019) -
TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia
por: Wegert, Jenny, et al.
Publicado: (2017) -
MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates
por: Jiménez Martín, Ovidio, et al.
Publicado: (2021) -
Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome
por: Welter, Nils, et al.
Publicado: (2021) -
Correction: Welter et al. Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome. Cancers 2021, 13, 5016
por: Welter, Nils, et al.
Publicado: (2021)